Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
Authors
Keywords
-
Journal
JOURNAL OF ANTIBIOTICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-29
DOI
10.1038/s41429-020-0320-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate
- (2019) Katsuhiko Mitachi et al. ORGANIC LETTERS
- Structure-based drug discovery by targeting N-glycan biosynthesis, dolichyl-phosphate N-acetylglucosaminephosphotransferase
- (2019) Michio Kurosu Future Medicinal Chemistry
- Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
- (2019) Xiaocui Wu et al. Frontiers in Cellular and Infection Microbiology
- Substrate Tolerance of Bacterial Glycosyltransferase MurG: Novel Fluorescence-Based Assays
- (2019) Katsuhiko Mitachi et al. ACS Infectious Diseases
- Structural absorption by barbule microstructures of super black bird of paradise feathers
- (2018) Dakota E. McCoy et al. Nature Communications
- An antimycobacterial pleuromutilin analogue effective against dormant bacilli
- (2018) Maddie R. Lemieux et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne’s model of dormancy
- (2018) Sajith Raghunandanan et al. JOURNAL OF ANTIBIOTICS
- Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors
- (2016) Katsuhiko Mitachi et al. ANALYTICAL BIOCHEMISTRY
- Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH
- (2016) Angelo Iacobino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis therapy for 2016 and beyond
- (2016) Michael Lauzardo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis
- (2016) Katsuhiko Mitachi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages
- (2015) Flavia Sorrentino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
- (2015) Rangappa S. Keri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I
- (2014) Shajila Siricilla et al. ANALYTICAL BIOCHEMISTRY
- Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors
- (2014) Shajila Siricilla et al. JOURNAL OF ANTIBIOTICS
- Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array
- (2013) R. Moure et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
- (2013) Juliane Ollinger et al. PLoS One
- TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
- (2013) Lanfranco Fattorini et al. Mediterranean Journal of Hematology and Infectious Diseases
- Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
- (2012) L. Rodrigues et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis
- (2012) Joy Debnath et al. JOURNAL OF MEDICINAL CHEMISTRY
- Divergent Effects of Mycobacterial Cell Wall Glycolipids on Maturation and Function of Human Monocyte-Derived Dendritic Cells
- (2012) Jolanta Mazurek et al. PLoS One
- Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis
- (2011) Frederick A. Sirgel et al. Microbial Drug Resistance
- Emergence and Molecular Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from the Delhi Region in India
- (2010) A. Khanna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Drug Combinations against Dormant Mycobacterium tuberculosis
- (2010) P. Filippini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis
- (2010) J. E. M. de Steenwinkel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
- (2009) Y. M. Ho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MenA Is a Promising Drug Target for Developing Novel Lead Molecules to Combat Mycobacterium tuberculosis
- (2009) Michio Kurosu et al. Medicinal Chemistry
- Dormant forms of Mycobacterium smegmatis with distinct morphology
- (2009) A. M. Anuchin et al. MICROBIOLOGY-SGM
- Metronidazole Lacks Activity againstMycobacterium tuberculosisin an In Vivo Hypoxic Granuloma Model of Latency
- (2008) Lee G. Klinkenberg et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started